Co-Delivery of Docetaxel and Resveratrol by Liposomes Synergistically Boosts Antitumor Efficiency against Prostate Cancer

Investigators designed PEGylated nano-liposomes for co-delivery Docetaxel and Resveratrol to evaluate antitumor efficiency of the combined drugs in prostate cancer.